NeoNavia AB is a privately held, founder-led Swedish MedTech company focused on advancing breast cancer diagnostics. Its first product, the NeoNavia Biopsy System, is an innovative breast biopsy solution that combines advanced needle insertion technology with superior sampling efficiency, ensuring precision and diagnostic reliability. With regulatory approvals in the EU and the US, NeoNavia is driving innovation and shaping the future of minimally invasive breast biopsy procedures.
NeoNavia GmbH is a fully operational, wholly owned subsidiary of NeoNavia AB, responsible for sales activities and reimbursement solutions in the DACH region.
Company Details
- Employees
- 4
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://neonavia.se/
- Competitors
- Aroniakraft, Dräger, Digital Clinical Safety, ENSE.
Neonavia Ab Questions
Neonavia Ab's website is https://neonavia.se/
Neonavia Ab's LinkedIn profile is https://www.linkedin.com/company/neonavia-ab
Neonavia Ab has
4 employees.
View email and phone details for 4
employees at Neonavia Ab.
Neonavia Ab's industry is
Medical Equipment Manufacturing
Neonavia Ab's categories are Medical Equipment Manufacturing
